203 related articles for article (PubMed ID: 25638604)
1. Clitoral involvement of squamous cell carcinoma of the vulva: localization with the worst prognosis.
Hinten F; van den Einden LC; Cissen M; IntHout J; Massuger LF; de Hullu JA
Eur J Surg Oncol; 2015 Apr; 41(4):592-8. PubMed ID: 25638604
[TBL] [Abstract][Full Text] [Related]
2. [Effectiveness of radical therapy in vulvar carcinoma. An analysis of 148 cases].
Bokhman JV; Maximov SJ; Ebert AD
Zentralbl Gynakol; 1997; 119(4):166-72. PubMed ID: 9206922
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral lymphatic vessel density in vulvar squamous cell carcinomas: a possible association with favorable prognosis.
Goes RS; Carvalho JP; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho FM
Int J Gynecol Pathol; 2012 Jan; 31(1):8-14. PubMed ID: 22123718
[TBL] [Abstract][Full Text] [Related]
4. An analysis of reported independent prognostic factors for survival in squamous cell carcinoma of the vulva: is tumor size significance being underrated?
Aragona AM; Cuneo NA; Soderini AH; Alcoba EB
Gynecol Oncol; 2014 Mar; 132(3):643-8. PubMed ID: 24418199
[TBL] [Abstract][Full Text] [Related]
5. Conservative clitoral preservation surgery in the treatment of vulvar squamous cell carcinoma.
Chan JK; Sugiyama V; Tajalli TR; Pham H; Gu M; Rutgers J; Monk BJ
Gynecol Oncol; 2004 Oct; 95(1):152-6. PubMed ID: 15385125
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of inguinal lymphadenectomy in vulvar squamous carcinoma: younger and older patients should be equally treated. A prospective study and literature review.
Panici PB; Tomao F; Domenici L; Giannini A; Giannarelli D; Palaia I; Di Donato V; Musella A; Angioli R; Muzii L
Gynecol Oncol; 2015 Jun; 137(3):373-9. PubMed ID: 25887098
[TBL] [Abstract][Full Text] [Related]
7. Stage IA vulvar squamous cell carcinoma: an analysis of tumor invasive characteristics and risk.
Yoder BJ; Rufforny I; Massoll NA; Wilkinson EJ
Am J Surg Pathol; 2008 May; 32(5):765-72. PubMed ID: 18379417
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer.
Woelber L; Mahner S; Voelker K; Eulenburg CZ; Gieseking F; Choschzick M; Jaenicke F; Schwarz J
Anticancer Res; 2009 Feb; 29(2):545-52. PubMed ID: 19331201
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma of the vulva stage IA: long-term results.
Magrina JF; Gonzalez-Bosquet J; Weaver AL; Gaffey TA; Leslie KO; Webb MJ; Podratz KC
Gynecol Oncol; 2000 Jan; 76(1):24-7. PubMed ID: 10620436
[TBL] [Abstract][Full Text] [Related]
10. [Is involvement of the clitoris in epidermoid carcinoma of the vulva an adverse prognostic sign?].
Masák L; Hudáková G
Ceska Gynekol; 1996 Oct; 61(5):299-301. PubMed ID: 9004977
[TBL] [Abstract][Full Text] [Related]
11. Radical surgery for T1 and T2 squamous cell carcinoma of the vulva through separate incisions.
Khobjai A; Srisomboon J; Charoenkwan K; Phongnarisorn C; Suprasert P; Siriaree S; Cheewakriangkrai C; Tantipalakorn C; Kietpeerakool C
J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S75-81. PubMed ID: 17722321
[TBL] [Abstract][Full Text] [Related]
12. Vulvar cancer: Two pathways with different localization and prognosis.
Hinten F; Molijn A; Eckhardt L; Massuger LFAG; Quint W; Bult P; Bulten J; Melchers WJG; de Hullu JA
Gynecol Oncol; 2018 May; 149(2):310-317. PubMed ID: 29555332
[TBL] [Abstract][Full Text] [Related]
13. Can preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios be used as predictive markers for lymph node metastasis in squamous cell carcinoma of the vulva?
Ertas IE; Gungorduk K; Akman L; Ozdemir A; Terek MC; Ozsaran A; Sanci M; Dikmen Y
Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):138-42. PubMed ID: 23992992
[TBL] [Abstract][Full Text] [Related]
14. Recurrent squamous cell carcinoma of the vulva: clinicopathologic determinants identifying low risk patients.
Preti M; Ronco G; Ghiringhello B; Micheletti L
Cancer; 2000 Apr; 88(8):1869-76. PubMed ID: 10760764
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva.
Raspagliesi F; Hanozet F; Ditto A; Solima E; Zanaboni F; Vecchione F; Kusamura S
Gynecol Oncol; 2006 Aug; 102(2):333-7. PubMed ID: 16466657
[TBL] [Abstract][Full Text] [Related]
16. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study.
Brantsch KD; Meisner C; Schönfisch B; Trilling B; Wehner-Caroli J; Röcken M; Breuninger H
Lancet Oncol; 2008 Aug; 9(8):713-20. PubMed ID: 18617440
[TBL] [Abstract][Full Text] [Related]
17. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
18. [Results of an individualized surgical therapy of vulvar carcinoma from 1973-1993].
Köhler U; Schöne M; Pawlowitsch T
Zentralbl Gynakol; 1997; 119 Suppl 1():8-16. PubMed ID: 9245126
[TBL] [Abstract][Full Text] [Related]
19. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the number and laterality of metastatic inguinal lymph nodes in vulvar cancer: revisiting the FIGO staging system.
Baiocchi G; Silva Cestari FM; Rocha RM; Lavorato-Rocha A; Maia BM; Cestari LA; Kumagai LY; Faloppa CC; Fukazawa EM; Badiglian-Filho L; Sant'ana Rodrigues I; Soares FA
Eur J Surg Oncol; 2013 Jul; 39(7):780-5. PubMed ID: 23518307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
